Issue Date: July 1, 2013
Europe Eyes Open Access To Drug Trial Data
A proposal by Europe’s drug regulatory authority to make data from clinical trials public met with immediate criticism from industry when it was announced last week. The head of the European Federation of Pharmaceutical Industries & Associations, a trade group known as EFPIA, warned that the European Medicines Agency’s proposal could expose competitively sensitive data on research done in Europe to drugmakers around the world.
At a . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society